ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,665Medicare Part D Prescriptions Filled, Including Refills

Rank: 25 out of 546

$545K Total Retail Price of All Prescriptions

Rank: 45 out of 546

225 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
85% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maine
Lower avg

Schedule Two
Controlled Substances

18% of this provider’s 225 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

23% of this provider’s 225 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 7,231 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $65 among peers.

Prescriptions per Patient

47 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maine
SIMVASTATIN 423 290 1 2
WARFARIN SODIUM 405 375 2 13
OMEPRAZOLE 401 297 3 4
FUROSEMIDE 357 269 4 5
METOPROLOL TARTRATE 331 213 5 6
HYDROCODONE-ACETAMINOPHEN 268 159 S3 6 8
LEVOTHYROXINE SODIUM 266 179 7 3
LISINOPRIL 262 170 8 1
SERTRALINE HCL 198 149 9 14
ATORVASTATIN CALCIUM 176 129 10 11
MELOXICAM 169 107 11 58
RANITIDINE HCL 167 111 12 23
LOSARTAN POTASSIUM 153 126 13 24
HYDROCHLOROTHIAZIDE 142 130 14 7
POTASSIUM CHLORIDE 132 109 15 30
GABAPENTIN 131 55 16 16
PAROXETINE HCL 128 100 17 43
AMLODIPINE BESYLATE 120 101 18 9
DONEPEZIL HCL 117 117 19 31
CYCLOBENZAPRINE HCL 111 42 R 20 34
METFORMIN HCL 107 40 21 10
OXYCODONE-ACETAMINOPHEN 106 44 S2 22 54
OXYCODONE HCL 103 49 S2 23 15
ISOSORBIDE MONONITRATE ER 100 66 24 32
CITALOPRAM HBR 97 58 25 21
ADVAIR DISKUS 92 52 26 20
RISPERIDONE 92 56 26 47
METOPROLOL SUCCINATE 89 75 28 17
TRAZODONE HCL 85 61 29 25
GLIPIZIDE 85 49 29 44
ZOLPIDEM TARTRATE 83 36 31 26
ATENOLOL 80 55 32 12
AZITHROMYCIN 79 45 33 55
SPIRIVA 77 42 34 28
ACETAMINOPHEN-CODEINE 73 46 S3 35 113
TRAMADOL HCL 71 33 36 19
PREDNISONE 70 37 37 29
CARVEDILOL 66 59 38 56
RAMIPRIL 64 52 39 155
ROPINIROLE HCL 64 15 39 64
PANTOPRAZOLE SODIUM 63 44 41 18
FENTANYL 63 51 S2 41 50
CYMBALTA 62 43 43 37
AMITRIPTYLINE HCL 62 35 R 43 48
NITROGLYCERIN PATCH 60 54 45 117
GLYBURIDE 59 43 R 46 45
FLUTICASONE PROPIONATE 59 32 46 42
NYSTATIN 58 41 48 97
DILTIAZEM ER 58 50 48 123
NEXIUM 57 31 50 52
DOXYCYCLINE HYCLATE 57 31 50 144
PROAIR HFA 56 41 52 27
MORPHINE SULFATE ER 54 0 S2 53 67
CIPROFLOXACIN HCL 54 45 53 84
ENALAPRIL MALEATE 54 51 53 59
ALLOPURINOL 53 49 56 41
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 21, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.